Ubs Asset Management Americas Inc Revolution Medicines, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 216,026 shares of RVMD stock, worth $8.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
216,026
Previous 241,447
10.53%
Holding current value
$8.8 Million
Previous $9.37 Million
4.46%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding RVMD
# of Institutions
275Shares Held
161MCall Options Held
260KPut Options Held
620K-
Vanguard Group Inc Valley Forge, PA14.9MShares$607 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$546 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$464 Million0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA11.3MShares$461 Million2.58% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$308 Million3.67% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.57B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...